General Information of the Compound
Compound ID
CP0552600
Compound Name
4-allyl-1-thioxo-2H-[1,2,4]triazolo[4,3-a]quinazolin-5-one
    Show/Hide
Structure
Formula
C12H10N4OS
Molecular Weight
258.306
Canonical SMILES
C=CCn1c2n[nH]c(=S)n2c2ccccc2c1=O
    Show/Hide
InChI
InChI=1S/C12H10N4OS/c1-2-7-15-10(17)8-5-3-4-6-9(8)16-11(15)13-14-12(16)18/h2-6H,1,7H2,(H,14,18)
    Show/Hide
InChIKey
HOAFKCJEEQOECV-UHFFFAOYSA-N
Physicochemical Property
logP
1.89279
Rotatable Bonds
2
Heavy Atom Count
18
Polar Areas
55.09
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
18

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 2363795
ChEMBL ID
CHEMBL1478489
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01252, Serine/threonine-protein kinase PLK1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000050 HEK293-A Homo sapiens (Human)  1
1
IC50 = 1310 nM
   TI
   LI
   LO
   TS